Search

Displaying all 3 results
DrugBest match

Insulin glargine

go.drugbank.com/drugs/DB00047
ApprovedInvestigational

Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancrea...

  1. Drug

    Insulin efsitora alfa

    go.drugbank.com/drugs/DB19013
    Approved

    Insulin efsitora alfa is under investigation in clinical trial NCT05662332 (A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting … Basal Insulin for the First Time (QWINT-1)).

    Synonyms: Insulin efsitora, Insulin efsitora alfa
  2. Drug

    Lixisenatide

    go.drugbank.com/drugs/DB09265
    ApprovedInvestigational

    Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA...

    Categories: insulin glargine and lixisenatide